The study found that in one drug only 1% of an estimated 276,000 serious adverse events had been reported. Researchers say they data emphasizes the need for better surveillance of the risk of injury. In other pharmaceutical news: biotechs react to the House drug pricing bill, another drugmaker admits to price fixing, a new medicine might help curb dementia-related delusions, and more.
from Kaiser Health News https://ift.tt/2DUgKmx
Rose
0 comments:
Post a Comment